RO-706293

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameRO-706293
Drug Alias NameRO-7062931
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingaporeTaiwanThailand +[8] 
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRoche R&D Center (China) LtdF. Hoffmann-La Roche Ltd
Inactive CompaniesF. Hoffmann-La Roche Ag
Active IndicationsHepatitis B
Inactive IndicationsHepatitis B, Chronic

Other Information

ATC CodeN/A
Related LinksN/A